Dr. Yanliang Zhang's lab at the University of Notre Dame focuses on advancing 3D bioprinting technology to create complex, functional blood vessel structures. By integrating various printing methods, their goal is to develop improved vascular tissues that can perform essential biological functions and facilitate tissue repair. This cutting-edge research has the potential to significantly impact regenerative medicine and organ engineering.

Dr. Matthew Webber's lab at the University of Notre Dame focuses on developing innovative insulin therapies for diabetes management. They aim to create a once-weekly insulin formulation that responds to blood glucose levels, making it easier for patients to control their diabetes. By combining advanced materials and chemical modifications, the lab seeks to improve patient adherence and enhance therapeutic outcomes while minimizing risks associated with insulin therapy.